Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRK-700 DDI Study with Digoxin and Midazolam
NCT03043248Phase 1Completed
- Sponsor
- Toray Industries
- Start
- Feb 2017
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of TRK-700 in neuropathic pain (2 cohorts), sponsored by Toray Industries. Primary endpoint: Area under the plasma drug concentration - time curve from administration to the last available concentration measurement at 72 hours. Started Feb 2017; status: completed.
02
Drugs
TRK-700
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT03043248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03043248.